Spine Biologics Market 2027 By Product, End User and Geography | The Insight Partners

Spine Biologics Market to 2027 - Global Analysis and Forecasts By Product (Bone Graft Substitutes, Spinal Allografts, Cell-based Matrix) ; End User (Hospitals, ASCs) and Geography

Report Code: TIPRE00006818 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Spine surgery is shifting from traditional devices to biologics. It consists of biomaterials that are used in the treatment of degenerative disc diseases, spinal cord injuries, and in bone fusion surgeries. The usage of these products is crucial in spine surgery. Spinal fusion is a procedure used to correct defects in vertebrae in the spine.

MARKET DYNAMICS

Spine Biologics market is anticipated to grow in the forecast period owing to Increasing prevalence of degenerative spine disorders, and a subsequent increase in treatment rates, advancements in bone grafting procedures. Moreover, increasing demand for minimally invasive procedures is also offering opportunities in the market growth during the forecast period.

MARKET SCOPE

The "Global Spine Biologics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Spine Biologics market with detailed market segmentation by type, end user and geography. The global Spine Biologics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Spine Biologics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Spine Biologics market is segmented on the basis of end user, and product. Based on product, the market is segmented as bone graft substitutes, spinal allografts, cell-based matrix. Based on end user, the market is segmented as Hospitals, ASCs.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Spine Biologics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Spine Biologics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Spine Biologics market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Spine Biologics market in these regions.

MARKET PLAYERS


The report covers key developments in the Spine Biologics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Spine Biologics market are anticipated to lucrative growth opportunities in the future with the rising demand for Spine Biologics in the global market. Below mentioned is the list of few companies engaged in the Spine Biologics market.

The report also includes the profiles of key Spine Biologics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  STRYKER
  •  ORTHOFIX HOLDINGS, INC.
  •  NUVASIVE, INC.
  •  K2M INC.
  •  DEPUY SYNTHES
  •  WRIGHT MEDICAL GROUP N.V.
  •  EXACTECH, INC.
  •  ZIMMER BIOMET
  •  ARTHREX, INC.
  •  MEDTRONIC INC.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Spine Biologics Market - By Product
1.3.2 Spine Biologics Market - By End User
1.3.3 Spine Biologics Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SPINE BIOLOGICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. SPINE BIOLOGICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. SPINE BIOLOGICS MARKET - GLOBAL MARKET ANALYSIS
6.1. SPINE BIOLOGICS - GLOBAL MARKET OVERVIEW
6.2. SPINE BIOLOGICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. SPINE BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BONE GRAFT SUBSTITUTES
7.3.1. Overview
7.3.2. Bone Graft Substitutes Market Forecast and Analysis
7.4. SPINAL ALLOGRAFTS
7.4.1. Overview
7.4.2. Spinal Allografts Market Forecast and Analysis
7.5. CELL-BASED MATRIX
7.5.1. Overview
7.5.2. Cell-based Matrix Market Forecast and Analysis

8. SPINE BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. ASCS
8.4.1. Overview
8.4.2. ASCs Market Forecast and Analysis

9. SPINE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Spine Biologics Market Overview
9.1.2 North America Spine Biologics Market Forecasts and Analysis
9.1.3 North America Spine Biologics Market Forecasts and Analysis - By Product
9.1.4 North America Spine Biologics Market Forecasts and Analysis - By End User
9.1.5 North America Spine Biologics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Spine Biologics Market
9.1.5.1.1 United States Spine Biologics Market by Product
9.1.5.1.2 United States Spine Biologics Market by End User
9.1.5.2 Canada Spine Biologics Market
9.1.5.2.1 Canada Spine Biologics Market by Product
9.1.5.2.2 Canada Spine Biologics Market by End User
9.1.5.3 Mexico Spine Biologics Market
9.1.5.3.1 Mexico Spine Biologics Market by Product
9.1.5.3.2 Mexico Spine Biologics Market by End User
9.2. EUROPE
9.2.1 Europe Spine Biologics Market Overview
9.2.2 Europe Spine Biologics Market Forecasts and Analysis
9.2.3 Europe Spine Biologics Market Forecasts and Analysis - By Product
9.2.4 Europe Spine Biologics Market Forecasts and Analysis - By End User
9.2.5 Europe Spine Biologics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Spine Biologics Market
9.2.5.1.1 Germany Spine Biologics Market by Product
9.2.5.1.2 Germany Spine Biologics Market by End User
9.2.5.2 France Spine Biologics Market
9.2.5.2.1 France Spine Biologics Market by Product
9.2.5.2.2 France Spine Biologics Market by End User
9.2.5.3 Italy Spine Biologics Market
9.2.5.3.1 Italy Spine Biologics Market by Product
9.2.5.3.2 Italy Spine Biologics Market by End User
9.2.5.4 Spain Spine Biologics Market
9.2.5.4.1 Spain Spine Biologics Market by Product
9.2.5.4.2 Spain Spine Biologics Market by End User
9.2.5.5 United Kingdom Spine Biologics Market
9.2.5.5.1 United Kingdom Spine Biologics Market by Product
9.2.5.5.2 United Kingdom Spine Biologics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Spine Biologics Market Overview
9.3.2 Asia-Pacific Spine Biologics Market Forecasts and Analysis
9.3.3 Asia-Pacific Spine Biologics Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Spine Biologics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Spine Biologics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Spine Biologics Market
9.3.5.1.1 Australia Spine Biologics Market by Product
9.3.5.1.2 Australia Spine Biologics Market by End User
9.3.5.2 China Spine Biologics Market
9.3.5.2.1 China Spine Biologics Market by Product
9.3.5.2.2 China Spine Biologics Market by End User
9.3.5.3 India Spine Biologics Market
9.3.5.3.1 India Spine Biologics Market by Product
9.3.5.3.2 India Spine Biologics Market by End User
9.3.5.4 Japan Spine Biologics Market
9.3.5.4.1 Japan Spine Biologics Market by Product
9.3.5.4.2 Japan Spine Biologics Market by End User
9.3.5.5 South Korea Spine Biologics Market
9.3.5.5.1 South Korea Spine Biologics Market by Product
9.3.5.5.2 South Korea Spine Biologics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Spine Biologics Market Overview
9.4.2 Middle East and Africa Spine Biologics Market Forecasts and Analysis
9.4.3 Middle East and Africa Spine Biologics Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Spine Biologics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Spine Biologics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Spine Biologics Market
9.4.5.1.1 South Africa Spine Biologics Market by Product
9.4.5.1.2 South Africa Spine Biologics Market by End User
9.4.5.2 Saudi Arabia Spine Biologics Market
9.4.5.2.1 Saudi Arabia Spine Biologics Market by Product
9.4.5.2.2 Saudi Arabia Spine Biologics Market by End User
9.4.5.3 U.A.E Spine Biologics Market
9.4.5.3.1 U.A.E Spine Biologics Market by Product
9.4.5.3.2 U.A.E Spine Biologics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Spine Biologics Market Overview
9.5.2 South and Central America Spine Biologics Market Forecasts and Analysis
9.5.3 South and Central America Spine Biologics Market Forecasts and Analysis - By Product
9.5.4 South and Central America Spine Biologics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Spine Biologics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Spine Biologics Market
9.5.5.1.1 Brazil Spine Biologics Market by Product
9.5.5.1.2 Brazil Spine Biologics Market by End User
9.5.5.2 Argentina Spine Biologics Market
9.5.5.2.1 Argentina Spine Biologics Market by Product
9.5.5.2.2 Argentina Spine Biologics Market by End User

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. SPINE BIOLOGICS MARKET, KEY COMPANY PROFILES
11.1. STRYKER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ORTHOFIX HOLDINGS, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NUVASIVE, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. K2M INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. DEPUY SYNTHES
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. WRIGHT MEDICAL GROUP N.V.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. EXACTECH, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ZIMMER BIOMET
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ARTHREX, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MEDTRONIC INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. STRYKER
2. ORTHOFIX HOLDINGS, INC.
3. NUVASIVE, INC.
4. K2M INC.
5. DEPUY SYNTHES
6. WRIGHT MEDICAL GROUP N.V.
7. EXACTECH, INC.
8. ZIMMER BIOMET
9. ARTHREX, INC.
10. MEDTRONIC INC.